Loading...

FITC anti-mouse Ly-6C Antibody

Pricing & Availability
Clone
HK1.4 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus C
Isotype
Rat IgG2c, κ
Ave. Rating
Submit a Review
Product Citations
publications
HK1dot4_FITC_011409.jpg
C57BL/6 bone marrow cells stained with HK1.4 FITC (gated on myeloid cell population)
  • HK1dot4_FITC_011409.jpg
    C57BL/6 bone marrow cells stained with HK1.4 FITC (gated on myeloid cell population)
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
128005 50 µg 72€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
128006 500 µg 235€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Most hematopoietic cells express one or more members of Ly-6 family. The expression of Ly-6 varies with development stage and activation. Ly-6C is a 14-17 kD GPI-linked surface protein expressed on mouse monocyte/macrophage cells, endothelial cells, neutrophils, and some T cell subsets. Ly-6C is reported to be an indicator of memory CD8+ T cells.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
L3 cloned CTL cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume or 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone HK1.4 does not block the binding of clone RB6-8C58.

Additional reported applications (for relevant formats of this clone) include: in vitro activation of T cells1-3 and immunohistochemistry of frozen sections4.

Application References
  1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (Activ)
  2. Herold KC, et al. 1990. Diabetes 39:815. (Activ)
  3. Havran WL, et al. 1988. J. Immunol. 140:1034 (Activ)
  4. Flanagan K, et al. 2008. J. Immunol. 180:3874. (IHC)
  5. Makaroff LE, et al. 2009. P. Natl. Acad. Sci. USA 106:4799. (FC)
  6. Zuber J, et al. 2009. Genes Dev. 23:877. (FC) PubMed
  7. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  8. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  9. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
Product Citations
  1. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  2. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  3. Zaman R, et al. 2021. Immunity. :. PubMed
  4. Combes F, et al. 2018. Neoplasia. 20:848. PubMed
  5. de la Rosa X, et al. 2018. Am J Pathol. 188:950. PubMed
  6. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  7. Duan Y, et al. 2019. Circ Res. 125:969. PubMed
  8. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  9. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  10. Fang C, et al. 2022. J Pathol. 256:310. PubMed
  11. Xin B, et al. 2022. Hepatology. 76:630. PubMed
  12. Du Y, et al. 2022. FASEB J. 36:e22248. PubMed
  13. Helfen A, et al. 2022. Neoplasia. 28:100792. PubMed
  14. Liu X, et al. 2022. Adv Sci (Weinh). 9:e2105650. PubMed
  15. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  16. Campisi L, et al. 2022. Nature. 606:945. PubMed
  17. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  18. McAlpine CS, et al. 2022. J Exp Med. 219: . PubMed
  19. Millar FR, et al. 2022. Cell Rep. 41:111596. PubMed
  20. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  21. Soni N, et al. 2022. FASEB Bioadv. 4:798. PubMed
  22. Marritt KL, et al. 2023. Front Immunol. 13:1087991. PubMed
  23. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  24. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  25. Hettwer J, et al. 2022. Cardiovasc Res. 118:2778. PubMed
  26. Fernández-García V, et al. 2022. Biomed Pharmacother. 148:112769. PubMed
  27. Chen K, et al. 2022. Adv Sci (Weinh). 9:e2104106. PubMed
  28. Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed
  29. Lopez R, et al. 2022. Nat Biotechnol. 40:1360. PubMed
  30. Sanmarco LM, et al. 2022. Nature. 611:801. PubMed
  31. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  32. Aso K, et al. 2023. Nat Commun. 14:984. PubMed
  33. Bautista CA, et al. 2023. Front Physiol. 14:1122348. PubMed
  34. He Y, et al. 2023. Biomolecules. 13:. PubMed
  35. Lin CH, et al. 2023. iScience. 26:106904. PubMed
  36. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  37. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  38. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  39. John S, et al. 2020. Sci Rep. 10:11377. PubMed
  40. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  41. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  42. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  43. Keeter WC, et al. 2022. Eur Heart J Open. 2:oeac028. PubMed
  44. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  45. Rødahl I, et al. 2021. STAR Protoc. 2:100842. PubMed
  46. You Y, et al. 2016. Sci Rep. 6:20630. PubMed
  47. Dong L, et al. 2021. Cancer Cell. . PubMed
  48. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  49. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  50. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  51. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  52. Shani O, et al. 2020. Cancer Res. 80:5317. PubMed
  53. Buzas K, et al. 2011. Cytokine. 55:429. PubMed
  54. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  55. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  56. Iwata H, et al. 2016. Nat Commun. 7:12849. PubMed
  57. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  58. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  59. McAlpine CS, et al. 2019. Nature. 566:383. PubMed
  60. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  61. Chen JS, et al. 2022. Sci Immunol. 7:eabl5652. PubMed
  62. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  63. Paprckova D, et al. 2022. Front Immunol. 13:1009198. PubMed
  64. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  65. Moreau GB, et al. 2020. Am J Trop Med Hyg. 103:1215. PubMed
  66. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  67. Mirakaj V, et al. 2014. J Exp Med. 211:1037. PubMed
  68. Park Y, et al. 2013. Cancer Res . 73:5669. PubMed
  69. Schlegel M, et al. 2018. J Clin Invest. 128:4711. PubMed
  70. Al-Sharea A, et al. 2017. Cell Cycle. 10.1016/j.atherosclerosis.2017.08.010. PubMed
  71. Bhattacharya P, et al. 2022. PLoS Negl Trop Dis. 16:e0010224. PubMed
  72. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  73. Shin SH, et al. 2022. Front Cell Neurosci. 16:844480. PubMed
  74. Eichin D, et al. 2015. PLoS One. 10: 0134721. PubMed
  75. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  76. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  77. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  78. Naler LB, et al. 2022. Commun Biol. 5:102. PubMed
  79. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  80. Körner A, et al. 2019. Nat Commun. 10:633. PubMed
  81. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  82. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  83. Han D, et al. 2021. J Immunol Res. 6688053:2021. PubMed
  84. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  85. Cao Y, et al. 2015. J Biol Chem. 290: 23050-23063. PubMed
  86. Körner A, et al. 2019. Proc Natl Acad Sci U S A. 116:20623. PubMed
  87. Kulkarni U, et al. 2019. Mucosal Immunol. 12:545. PubMed
  88. Suresh MV, et al. 2019. JCI Insight. 4:e133103. PubMed
  89. Liu T, et al. 2022. Front Immunol. 13:901349. PubMed
  90. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  91. He Y, et al. 2021. Front Immunol. 12:641206. PubMed
  92. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
  93. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  94. Xu Y, et al. 2016. Arthritis Rheum. 67: 225-237. PubMed
  95. Ma H, Wan S, Xia C 2016. J Leukoc Biol. 99: 1121 - 1129. PubMed
  96. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  97. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  98. Körner A,et al. 2017. Cell Death Differ.. 10.1038/cdd.2017.177. PubMed
  99. He J, et al. 2019. J Clin Invest. 130. PubMed
  100. Li Y, et al. 2020. Cell Reports. 27(10):2809-2816.e3.. PubMed
  101. Monteran L, et al. 2022. Nat Commun. 13:5797. PubMed
  102. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  103. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  104. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  105. Tan X, et al. 2015. Sci Rep. 5: 15702. PubMed
  106. Smith CA, et al. 2019. JCI Insight. 4. PubMed
  107. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  108. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  109. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  110. Poczobutt JM, et al. 2021. Am J Respir Cell Mol Biol. 64:629. PubMed
  111. Garcia-Bonilla L, et al. 2014. J Immunol. 193:2531. PubMed
  112. Lee S, et al. 2011. J Immunol. 186:6972. PubMed
  113. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  114. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  115. Derada Troletti C, et al. 2021. Cell Reports. 35(9):109201. PubMed
  116. Hou PP, et al. 2020. Molecular Cell. 78(6):1192-1206.e10. PubMed
  117. Xu G, et al. 2020. Cell Rep. 32:108170. PubMed
  118. Moore J, et al. 2015. Am J Physiol Heart Circ Physiol. 309: 906-917. PubMed
  119. León-Cabrera S, et al. 2014. Int J Biol Sci. 9 948 . PubMed
  120. Alvarez-Breckenridge C, et al. 2012. J Virol. 86:4566. PubMed
  121. Hightower RM, et al. 2019. Mol Ther. 28:189. PubMed
  122. Zhao T, et al. 2022. JCI Insight. 7:. PubMed
  123. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  124. Liu Y, et al. 2015. BioMed Res Int. 2015 563425. PubMed
  125. Kwak T, et al. 2020. Cell Reports. 33(13):108571. PubMed
  126. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  127. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  128. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
  129. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  130. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  131. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  132. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  133. Hobbs BE, et al. 2021. Pathogens. 10:. PubMed
  134. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  135. Knuplez E, et al. 2021. British Journal of Pharmacology. 178(5):1234-1248. PubMed
  136. Roediger B et al. 2018. Cell. 175(2):530-543 . PubMed
  137. Meng Michelle Xu et al. 2017. Immunity. 47(2):363-373 . PubMed
  138. Caballero S, et al. 2017. Invest Ophthalmol Vis Sci. 58:5164. PubMed
  139. Donlan AN, et al. 2021. JCI Insight. 6: . PubMed
  140. Tyagi A, et al. 2021. Nat Commun. 12:474. PubMed
  141. Tang S, et al. 2022. Virol J. 19:32. PubMed
  142. Rahtes A, et al. 2020. Front Immunol. 1.484722222. PubMed
  143. Aryal B, et al. 2016. Nat Commun. 7:12313. PubMed
  144. Ngkelo A, et al. 2016. J Exp Med. 213: 1353 - 1374. PubMed
  145. Garcia-Bonilla L, et al. 2015. J Neurosci. 35: 14783 - 14793. PubMed
  146. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  147. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  148. Asahara M, et al. 2022. PLoS One. 17:e0276135. PubMed
  149. Dye BR, et al. 2020. Biomaterials. 234:119757. PubMed
  150. Lei Y, et al. 2021. Sci Adv. 7:. PubMed
  151. Guan D, et al. 2021. Cell Death Dis. 12:431. PubMed
  152. Tummala G, et al. 2021. Invest Ophthalmol Vis Sci. 62:41. PubMed
  153. Chetty A, et al. 2021. Cell Host Microbe. 29:579. PubMed
  154. Chavkin NW, et al. 2021. J Am Heart Assoc. 10:e019904. PubMed
  155. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  156. Aguado B, et al. 2015. Sci Rep. 5: 17566. PubMed
  157. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  158. Hilt ZT, et al. 2019. JCI Insight. 4:5. PubMed
  159. Jones GS, et al. 2020. mSphere. 5:. PubMed
  160. Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed
  161. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  162. Reinke S, et al. 2020. Cell Reports. 30(8):2501-2511. PubMed
  163. Ershaid N, et al. 2019. Nat Commun. 10:4375. PubMed
  164. Abe H, et al. 2019. Nat Commun. 10:2824. PubMed
  165. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  166. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
RRID
AB_1186134 (BioLegend Cat. No. 128005)
AB_1186134 (BioLegend Cat. No. 128006)

Antigen Details

Structure
14-17 kD protein (134 amino acids), member of the Ly-6 family of GPI linked protein. Ly6 family members share structure homology throughout a distinctive cystein rich protein domain that incorporates O-linked carbohydrates.
Distribution

Ly-6C is expressed primarily on bone marrow myeloid populations, monocytes/macrophages, neutrophils, endothelial cells, and some T cell subsets. Ly-6C is also a marker of memory CD8+ T cells.

Cell Type
Endothelial cells, Macrophages, Monocytes, Neutrophils, T cells
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
2. Cerwenka A, et al. 1998. J. Immunol. 161:97.

Gene ID
17067 View all products for this Gene ID
UniProt
View information about Ly-6C on UniProt.org
Go To Top Version: 2    Revision Date: 12-09-2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account